KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS

Clinical trials for KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS trials appear

Sign up with your email to follow new studies for KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets 'Undruggable' KRAS cancer mutations in first human trial

Disease control Recruiting now

This early-stage study is testing a new oral drug called AMG 410, alone or with other treatments, for people with advanced solid tumors that have KRAS gene changes. The main goals are to find the safest and most effective dose and to see how the body processes the drug. Researche…

Matched conditions: KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS

Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS

Get alerted when new KRAS ALTERED ADVANCED OR METASTATIC SOLID TUMORS trials appear

New pill targets 'Undruggable' KRAS cancer mutations in first human trial